Santen Pharmaceutical Co.... (SNPHF)

PNK: SNPHF · Real-Time Price · USD

9.80

-2.66 (-21.35%)

At close: Apr 29, 2025, 3:09 PM

Santen Pharmaceutical Balance Sheet Statement

Financials in JPY. Fiscal year is April - March.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
Cash & Equivalents	94.58B	57.9B	83.01B	62.89B	91.43B	70.8B	69.28B	53.3B	99.8B
Short-Term Investments	379M	774M	1.29B	527M	452M	267M	472M	333M	234M
Long-Term Investments	33.4B	36.59B	34.95B	36.54B	30.4B	29.78B	35.3B	29.56B	44.3B
Other Long-Term Assets	10.77B	5.98B	6B	4.39B	2.27B	2.09B	3.33B	2.46B	2.34B
Receivables	90.54B	107.17B	99.59B	95.99B	87B	84.62B	78.65B	70.97B	66B
Inventory	43.19B	39.35B	37.14B	41.58B	35.28B	35.23B	30.64B	28.5B	25B
Other Current Assets	7.45B	8.91B	9.68B	5.78B	4.84B	4.09B	4.79B	4.24B	3.95B
Total Current Assets	236.14B	213.33B	229.43B	206.23B	218.56B	194.74B	183.37B	157.01B	194.74B
Property-Plant & Equipment	71.58B	66.17B	56.29B	39.49B	35.6B	31.7B	29.71B	28.55B	27.99B
Goodwill & Intangibles	83.82B	96.31B	130.22B	112.88B	119.85B	131.11B	134.5B	102.81B	83.68B
Total Long-Term Assets	199.56B	207.85B	230.55B	196.12B	190.21B	196.44B	205.09B	165.77B	160.66B
Total Assets	435.7B	421.18B	459.98B	402.35B	408.77B	391.19B	388.46B	322.78B	355.4B
Account Payables	43.53B	44.95B	41.19B	38.11B	32.58B	32.08B	29.74B	23.94B	24.5B
Deferred Revenue	n/a	-3.06B	-13.96B	-2.91B	-5.73B	-500M	-4.1B	-9.33B	-9.54B
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	41.47B	44.56B	54.64B	40.44B	35.02B	28.58B	32.46B	29.5B	48.73B
Total Current Liabilities	92.8B	89.5B	95.82B	78.55B	67.6B	60.66B	62.2B	53.43B	73.23B
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	37.53B	36.79B	24.79B	16.75B	38.61B	37.95B	38.7B	15.46B	22.16B
Total Long-Term Liabilities	37.53B	38.38B	27.31B	16.75B	38.61B	37.95B	38.7B	15.46B	22.16B
Total Liabilities	130.33B	127.88B	123.13B	95.3B	106.21B	98.61B	100.91B	68.89B	95.39B
Total Debt	35.16B	36.21B	32.93B	10.15B	12.33B	4.06B	7.6B	16.93B	22.48B
Common Stock	8.78B	8.7B	8.67B	8.53B	8.37B	8.25B	8.03B	7.79B	7.7B
Retained Earnings	240.03B	238.07B	290.48B	270.76B	273.42B	258.66B	249.22B	223.42B	221.94B
Comprehensive Income	n/a	37.78B	29.69B	20.43B	13.37B	16.46B	19.92B	15.63B	22B
Shareholders Equity	306.06B	293.98B	337.49B	307.58B	302.87B	290.9B	285.82B	253.06B	260.01B
Total Investments	24.41B	37.36B	36.24B	37.06B	30.85B	30.04B	35.77B	29.89B	44.53B